Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2

Kidney International

Volumn 59, Issue 6, 2001, Pages 2084-2094

  Clayton, Aled ^a   Thomas, Janet ^a   Thomas, Gareth J ^a   Davies, Malcolm ^a   Steadman, Robert ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cell proliferation; Extracellular matrix; Fibrosis; Interstitial inflammation; Progressive renal disease; Prosteoglycans; Syndecan family

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BB; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; SULFATE; SULFUR 35; SYNDECAN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY FIBROSIS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035018302     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.0590062084.x     Document Type: Article

References (57)

1. Cattell V: Macrophages in acute glomerular inflammation. (editorial) Kidney Int 45:945-952, 1994
2. Risdon RA, Sloper JAC, De Wardener HE: Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerular nephritis. Lancet 17:363-366, 1968
3. Bohle A, Mackensen-Haen H, Gise HV: Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: A morphometric contribution. Am J Nephrol 7:421-433, 1987
4. Strutz F, Müller GA: On the progression of chronic renal disease. Nephron 69:371-379, 1995
5. Strutz F, Müller GA: First Gottingen symposium on renal fibrosis: Prevention and progression (7-9 July 1995). Nephrol Dial Transplant 11:737-739, 1996
6. Strutz F, Müller GA: Interstitial pathomechanisms underlying progressive tubulointerstitial damage. Kidney Blood Press Res 22:71-80, 1999
7. Rodemann HP, Müller GA, Knecht A, et al: Fibroblasts of rabbit kidney in culture 1: Characterization and identification of cell-specific markers. Am J Physiol 261:F283-F291, 1991
8. Clayton A, Steadman R, Williams JD: Cells isolated from the human cortical interstitium resemble myofibroblasts and bind neutrophils in an ICAM-1-dependnet manner. J Am Soc Nephrol 8:604-615, 1997
9. Clayton A, Steadman R: ICAM-1 interactions in the renal interstitium: A novel activator of fibroblasts during nephritis. Histol Histopathol 14:861-870, 1999
10. Clayton A, Evans RA, Pettit E, et al: Cellular activation through the ligation of intercellular adhesion molecule-1. J Cell Sci 111:443-453, 1998
11. Norman JT, Fine LG: Progressive renal disease: Fibroblasts, extra-cellular matrix, and integrins. Exp Nephrol 7:167-177, 1999
12. Coutts JC, Gallagher JT: Receptors for fibroblast growth factors. Immunol Cell Biol 73:584-589, 1995
13. Gallagher JT: Heparan sulphate and protein recognition; Binding specificities and activation mechanisms. Adv Exp Med Biol 376: 125-134, 1995
14. Hildebrand A, Romaris M, Ramsmussen LM, et al: Interaction of the small interstitial proteoglycan biglycan, decorin and fibromodulin with transforming growth factor-β. Biochem J 302:527-534, 1994
15. Humes HD, Nakamura T, Cieslinski DA, et al: Role of proteoglycans and cytoskeleton in the effects of TGF-beta1 on renal proximal tubule cells. Kidney Int 43:575-584, 1993
16. Kanwar Y: Biophysiology of glomerular filtration and proteinuria of molecular origin. Lab Invest 51:7-21, 1984
17. Groffen AJ, Ruegg MA, Dijkman H, et al: Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem 46:19-27, 1998
18. Raats CJ, Van Den Born J, Berden JH: Glomerular heparan sulfate alterations: Mechanisms and relevance for proteinuria. Kidney Int 57:385-400, 2000
19. Van Der Woude FJ, Van Det NF: Heparan sulphate proteoglycans and diabetic nephropathy. Exp Nephrol 5:180-188, 1997
20. Bernfield M, Kokenyesi R, Kato M, et al: Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 8:365-393, 1992
21. Abboud HE: Growth factors in glomerulonephritis. Kidney Int 43:252-257, 1993
22. Bonneh-Barkay D, Shlissel M, Berman B, et al: Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors. J Biol Chem 272:12415-12421, 1997
23. Ki CW, Goldberger OA, Gallo RL, et al: Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol Biol Cell 5:797-805, 1994
24. Rapraeger A, Krufla A, Olwin BB: Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705-1708, 1991
25. Gallagher JT: Heparan sulfates as membrane bound receptors for the fibroblast growth factors. Eur J Clin Biochem 32:239-247, 1994
26. Morita H, Shinzato T, David G, et al: Basic fibroblast growth factor-binding domain of heparan sulfate in the human glomerulosclerosis and renal tubulointerstitial fibrosis. Lab Invest 71:528-535, 1994
27. Mossmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983
28. Thomas GJ, Bayliss MT, Harper K, et al: Glomerular mesangial cells in vitro synthesize an aggregating proteoglycan immunologically related to versican. Biochem J 302:49-56, 1994
29. Thomas GJ, Shrëwing L, McCarthy KJ, et al: Rat mesangial cells in vitro synthesize a spectrum of proteoglycan species including those of the basement membrane and interstitium. Kidney Int 48:1278-1289, 1995
30. Yanagishita M, Hascall VC: Effects of monensin on the synthesis, transport, and intracellular degradation of proteoglycans in rat ovarian granulosa cells in culture. J Biol Chem 260:5445-5455, 1985
31. Yanagishita M, Hascall VC: Proteoglycans synthesized by rat ovarian granusola cells in culture: Isolation, fractionation, and characterization of proteoglycans associated with the cell layer. J Biol Chem 259:10620-10629, 1984
32. Keller KM, Brauer PR, Keller JM: Modulation of cell surface heparan sulfate structure by growth of cells in the presence of chlorate. Biochemistry 28:8100-8107, 1989
33. Kojima T, Shworak NW, Rosenberg RD: Molecular cloning and expression of two distinct cDNA-encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line. J Biol Chem 267:4870-4877, 1992
34. Cizmeci-Smith GLE, Youkey J, Showalter LJ, et al: Syndecan-4 is a primary response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17:172-180, 1997
35. Roghani M, Moscatelli D: Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J Biol Chem 267:22156-22162, 1992
36. Rapraeger AC, Krufka A, Olwin BB: Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705-1708, 1991
37. Schriever C, Breithardt G, Schmidt A: Undersulfation of proteoheparan sulfate stimulates the expression of basic fibroblast growth factor and protein synthesis but suppresses replication of coronary smooth muscle cells. Biol Chem 378:701-706, 1997
38. Floege J, Eng E, Lindner V, et al: Rat glomerular mesangial cells synthesize basic fibroblast growth factor. J Clin Invest 90:2362-2369, 1992
39. Fernig DG, Gallagher JT: Fibroblast growth factors and their receptors: An information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res 5:353-377, 1994
40. Goldfarb M: The fibroblast growth factor family. Cell Growth Differ 1:439-445, 1990
41. Johnson D, Williams LT: Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60:1-41, 1993
42. Emoto N, Isozaki O, Ohmura E, et al: Degradation of cell surface heparan sulfates decreases the high affinity binding of basic FGF to endothelial cells, but not to FRTL-5 rat thyroid cells. Thyroid 5:455-460, 1995
43. Jayson GC, Gallagher JT: Heparin oligosaccharides: Inhibitors of the biological activity of bFGF on Caco-2 cells. Br J Cancer 75:9-16, 1997
44. Jayson GC, Lyon M, Paraskeva C, et al: Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J Biol Chem 273:51-57, 1998
45. Pye DA, Kumar S: Endothelial and fibroblast cell-derived heparan sulphate bind with differing affinity to basic fibroblast growth factor. Biochem Biophys Res Commun 248:889-895, 1998
46. Brickman YG, Ford MD, Gallagher JT, et al: Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development. J Biol Chem 273:4350-4359, 1998
47. Guimond S, Maccarana M, Olwin BB. et al: Activating and inhibitory heparin sequences for FGF-2 (basic FGF): Distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem 268:23906-23914, 1993
48. Carey D: Syndecans: Multifunctional cell-surface co-receptors. Biochem J 327:1-16, 1997
49. Pye DA, Gallagher JT: Monomer complexes of basic fibroblast growth factor and heparan sulfate oligosaccharides are the minimal functional unit for cell activation. J Biol Chem 274:13456-13461, 1999
50. Phillips AO, Topley N, Morrisey K, et al: Basic fibroblast growth factor stimulates the release of pre-formed TGF-β1 from human proximal tubular cells in the absence of de-novo gene transcription or mRNA translation. Lab Invest 76:591-600, 1997
51. Okada H, Strutz F, Danoff TM, et al: Possible mechanisms of renal fibrosis. Contrib Nephrol 118:147-154, 1996
52. Okada H, Strutz F, Danoff TM, et al: Possible pathogenesis of renal fibrosis. Kidney Int 49(Suppl 54):S37-S38, 1996
53. Muller GA, Schettler V, Muller CA, et al: Prevention of progression of renal fibrosis: How far are we? Kidney Int 49(Suppl 54):S75-S82, 1996
54. Morita H, David G, Mizutani A. et al: Heparan sulfate proteoglycans in the human sclerosing and scarring kidney: Changes in heparan sulfate moiety. Contrib Nephrol 107:174-179, 1994
55. Muller GA, Rodemann HP: Characterization of human and renal fibroblasts in health and disease. I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proved interstitial fibrosis. Am J Kidney Dis 17:680-683, 1991
56. Rodemann HP, Müller GA: Characterisation of human renal fibroblasts in health and disease. Ii. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am J Kidney Dis 17:684-686, 1991
57. Jaakkola P, Maatta A, Jalkanen M: The activation and composition of Fire (an Fgf-inducible response element) differ in a cell type- and growth factor-specific manner. Oncogene 17:1279-1286, 1998